Home » Newsletters » BioWorld Science

BioWorld Science

April 5, 2000

View Archived Issues

Array BioPharma and Lilly form drug discovery collaboration

CollaGenex seeks FDA approval for new dosage form of Periostat

Karo Bio to acquire Novalon

Significant progress reported by Genzyme Molecular Oncology for 1999

Aventis launches Arava in Canada for treatment of rheumatoid arthritis

First phase II clinical trial of ABX-IL-8 begins in psoriasis

New phosphoglycolipid useful for protecting against cardiac ischemia-reperfusion damage

Chemokine receptor modulators in early development at AstraZeneca

Helsinn initiates phase III testing of in-licensed antiemetic

Carboxylic acid PPAR modulators presented by Ono

Merck's new GABA-A receptor modulators particularly useful for Alzheimer's disease

Scios compounds useful for conditions characterized by excess p38alpha or TGF-beta activity

Merck describes preparation and use of new anticoagulants

Uprima to be considered for ED next week by FDA advisory committee

Another indication for Enbrel will be discussed at advisory committee meeting

Novel tubulin-binding antimitotic agent characterized in vitro by Abbott scientists

Celgene's IMiDs and thalidomide show activity as COX-2 inhibitors

WP-769: a doxorubicin analogue that combines oral activity and enhanced effect against topo II

Promising flavonoid discovered by Dutch investigators for preventing doxorubicin cardiotoxicity

Ro-31-7453: extensive preclinical and early clinical data presented this week to the AACR

DuPont licenses two cardiac compounds from Adenosine Therapeutics

Clinical study suggests SuperGen's Nipent effective in treating GVHD

FDA gives go-ahead for Access to commence OraDisc clinical trials

Matrix files initial section of IntraDose NDA with FDA

German researchers provide data supporting therapy with S-4718 + ciclosporin in cardiac transplants

Efficacy and mechanism of action of FR-167653 in protecting against lung I/R injury

Newly formed company to market TOBI in the Dutch market

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...